TNC has been shown to be overexpressed at the mRNA and protein levels in tumor tissue from patients with NSCLC compared with adjacent normal tissue, and its expression is correlated with unfavorable clinical outcomes, larger tumor size, lymph node metastasis, and disease recurrence [46,88,90]. Here, TNC is linked to non-small cell lung carcinoma.